Press Release: NextSource Biotechnology : NextSource Biotechnology Gains FDA Approval for Use of Tradename Gleostine™ (Lomustine), an Anti-Cancer Chemotherapy Agent

MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "matured" and "innovative drugs" in today's global healthcare market. The product name change from...